Autoimmune Gastrointestinal Dysmotility (AGID) Evaluation
Identification of autoimmune gastrointestinal dysmotility (AGID) can result in early diagnosis of an associated cancer and reversibility of symptoms with immunotherapy. Dr. Andrew McKeon will review the diagnostic testing algorithm for autoimmune gastrointestinal dysmotility, define the clinical utility of an AGID evaluation, and describe interpretation of laboratory testing.
- Andrew McKeon, MB, BCh, MD, consultant in the Neuroimmunology Laboratory in the Division of Clinical Biochemistry and Immunology, Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota
Forward to a Colleague
Share this presentation with:
If you have questions, e-mail .